AIDS drug survives Tanox: Genentech license launches new team at TaiMed Biologics

Corporate News Releases - The Healthcare Sales & Marketing Network, 04/14/2008

A promising HIV/AIDS treatment drug formerly in the Tanox Inc. fold remains in the Houston pipeline. TaiMed Biologics Inc. will conduct clinical trials of TNX-355 - also known as Ibalizumab - from a location on the West Loop near the former Tanox headquarters in suburban Bellaire.

Print Article Summary Cat 2 CME Report